Skip to main content

Table 1 Characteristics of 5,057 patients who were analyzed in the study. The patients initiated ART in 2008 to 2011 at the Immune Suppression Syndrome Clinic in Mbarara, Uganda

From: Predictors of dropout from care among HIV-infected patients initiating antiretroviral therapy at a public sector HIV treatment clinic in sub-Saharan Africa

Variable

 

Age

33 (28–40)a

Sex, Female

63.9 %

Education

 

 No education

5.5 %

 Primary

62.1 %

 Secondary or more

32.5 %

Time to clinic

 

 ≤1 h

14.8 %

 1-2 h

20.4 %

 2-3 h

21.9 %

 ≥4 h

43.0 %

Marital status

 

 Separated

13.2 %

 Divorced

5.7 %

 Widowed

16.8 %

 Single

10.0 %

 Married

54.4 %

Year of ART initiation

 

 2008

26.1 %

 2009

19.6 %

 2010

22.0 %

 2011

32.2 %

Opportunistic infections

 

 Tuberculosis, history of

5.9 %

 Kaposi’s sarcoma diagnosis

1.6 %

 Cryptococcosis, history of

1.2 %

 Esophagitis

2.2 %

 Oral candidiasis

17.2 %

 Chronic diarrhea

11.3 %

 Weight loss ≥10 %

12.9 %

 HIV-associated dementia

0.57 %

CD4+ T-cell counts (cells/μL)

 

  < 100

27.4 %

 100–200

25.9 %

 200–349

36.6 %

  ≥ 350

10.1 %

Hemoglobin (g/dl)

12.3 (11.0–13.7)

Neutrophils (x 103 cells/μL)

1.7 (1.1–2.4)

Eosinophils (x 103 cells/μL)

0.09 (0.04–0.20)

Platelets (x 103 cells/μL)

208 (155–268)

Lymphocytes (x 103 cells/μL)b

1.6 (1.1–2.0)

Initial ART regimens

 

 AZT, 3TC, NVP

58.5 %

 AZT, 3TC, EFV

15.1 %

 TDF, 3TC/FTC, EFV

19.4 %

 TDF, 3TC/FTC, NVP

2.9 %

 D4T, 3TC, EFV/NVP

4.1 %

  1. AZT zidovudine, 3TC lamivudine, D4T stavudine, NVP nevirapine, EFV efavirenz, TDF tenofovir
  2. aMedian (Interquartile range) unless otherwise specified
  3. bTotal lymphocyte count (TLC)